AVITA Medical (RCEL) Receivables - Other (2019 - 2024)
AVITA Medical (RCEL) posted Receivables - Other of -$55000.0 for Q4 2024, down 149.55% on a QoQ basis from $111000.0 in Q3 2024, and up 67.84% year-over-year from -$32770.0 in Q1 2024.
AVITA Medical (RCEL) Receivables - Other (2019 - 2024) Analysis & Trends
AVITA Medical's Receivables - Other history runs 6 years deep, the most recent figure standing at -$55000.0 for Q4 2024.
- Quarterly Receivables - Other rose 67.84% year-over-year to -$55000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$3.5 million (down 3623.47% YoY) and the FY2024 annual result came in at $56000.0, up 106.45% from the prior year.
- Receivables - Other was -$55000.0 for Q4 2024 at AVITA Medical, down from $111000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $3.5 million in Q2 2021 and bottomed at -$3.3 million in Q3 2021.
- A 5-year average of $431000.0 and a median of $347000.0 in 2020 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2020 — Receivables - Other surged 947.62% — and 2021, when it tumbled 998.38%.
- AVITA Medical's Receivables - Other stood at $440000.0 in 2020, then decreased by 30.0% to $308000.0 in 2021, then tumbled by 65.58% to $106000.0 in 2022, then slumped by 261.32% to -$171000.0 in 2023, then jumped by 67.84% to -$55000.0 in 2024.
- Business Quant data shows RCEL's Receivables - Other at -$55000.0 in Q4 2024, $111000.0 in Q3 2024, and $94000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -55,000.00 |
| Dec 31, 2024 | -55,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | -171,000.00 |
| Dec 31, 2023 | -171,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 442,000.00 |
| Jun 30, 2023 | 442,000.00 |
| Mar 31, 2023 | 516,000.00 |
| Mar 31, 2023 | 516,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 792,000.00 |
| Sep 30, 2022 | 792,000.00 |